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Simultaneous infection with multiple pathogens of the
same species occurs with HIV, hepatitis C, Epstein-Barr
virus, dengue, tuberculosis, and malaria. However, avail-
able methods do not distinguish among or quantify
pathogen genotypes in individual patients; they also cannot
test for novel insertions and deletions in genetically modi-
fied organisms. The strategy reported here accomplishes
these goals with real-time polymerase chain reaction
(PCR) and capillary electrophoresis. Real-time PCR with
allotype-specific primers defines the allotypes (strains)
present and the intensity of infection (copy number).
Capillary electrophoresis defines the number of genotypes
within each allotype and the intensity of infection by geno-
type. This strategy can be used to study the epidemiology
of emerging infectious diseases with simultaneous infection
by multiple genotypes, as demonstrated here with malaria.
It also permits testing for insertions or deletions in geneti-
cally modified organisms that may be used for bioterrorism. 
S
imultaneous infection with multiple pathogens of the
same species occurs in human patients with HIV, hep-
atitis C, Epstein-Barr virus, dengue, tuberculosis, and
malaria (1–7). However, available laboratory methods do
not distinguish among pathogen genotypes in samples
from individual patients. They do not permit the identifica-
tion or quantitation of genotypes in samples with multiple
pathogens of the same species, or the identification of size
polymorphisms produced by insertions and deletions. 
Conventional polymerase chain reaction (PCR) with
agarose gel electrophoresis permits the identification of
pathogen allotypes (strains) in human blood and tissue and
an assessment of the sizes of their amplicons but does not
define allotype copy number or genotype copy number.
Real-time PCR permits identification and quantitation of
allotypes (8,9) but does not permit the identification of
genotypes within allotypes. 
From the epidemiologic perspective, a molecular strat-
egy to define the allotypes and genotypes of human
pathogens and their copy numbers would permit one to
study the dynamics of simultaneous infection with multi-
ple genotypes in ways that have been impossible. For
example, this knowledge could be used to identify novel
genotypes (size polymorphisms) resulting from insertions
and deletions at polymorphic loci. 
From the bioterrorism perspective, a strategy to identi-
fy size polymorphisms (insertions and deletions) in critical
regions of pathogen genomes would be of immense value.
This information could be used to test for deletions in reg-
ulatory (suppressor) regions and for the insertion of new
genes in regions controlled by strong promoters. Available
methods do not permit the rapid identification of size poly-
morphisms within allotypes or the quantitation of individ-
ual pathogen genotypes. 
To address this challenge, we used real-time PCR and
capillary electrophoresis. Real-time PCR with allotype-
specific primers permits one to define the allotypes present
and their copy number (8,9). Capillary electrophoresis per-
mits one to define individual genotypes within allotypes
and genotype copy number. The combination of real-time
PCR and capillary electrophoresis also permits the identi-
fication of insertions and deletions in potentially critical
regions of pathogen genomes. 
Materials and Methods
Collection of Patient Samples and 
Isolation of Pathogen DNA
Using fingersticks, filter paper blot samples (S & S
#903 Blood Collection Cards, Schleicher & Scheuell
Bioscience, Keene, NH, USA) containing 50 µL of blood
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infection in Mali. These samples were obtained in a
prospective study of asymptomatic P. falciparum infection
in the village of Missira (160 km northwest of Bamako),
after review and approval by the University of Bamako
Institutional Review Board (IRB) in Bamako and the
Tulane University IRB in New Orleans. Before obtaining
informed consent from the participants (after IRB reviews
and approvals), the protocol was reviewed with the chief
and elders of the village and the women’s council. After
those additional reviews and approvals, informed consent
was obtained from persons >18 years of age and from the
parents and guardians of children <17 years of age before
obtaining blood samples. DNA was isolated from filter
paper blots and blood samples by using the QIAamp DNA
Mini Kit (Qiagen, Valencia, CA, USA). 
Control template DNA was obtained from cultured par-
asites (10) by using the QIAamp DNA Blood Mini Kit
(Qiagen). Cloned isolates used as controls for the 4 known
allotypes of the polymorphic block 2 region of merozoite
surface protein 1 (msp1) were Indochina I/CDC for
MAD20, Haiti 135 for K1, 7G8 for RO33, and OK/JC 5 for
MAD20/RO33 hybrid allotype parasites (11–13). DNA
template concentrations were estimated from standard
curves by plotting the fluorescence of 5 DNA standards
with concentrations of 1 µg/mL (1,000 ng/ml), 100 ng/mL,
10 ng/mL, 1 ng/mL, and 0 ng/mL (blank or negative con-
trol) vs. the log10 of template DNA concentration by using
PicoGreen dye (Molecular Probes, Eugene, OR, USA) with
the VersaFluor fluorometer (Bio-Rad, Hercules, CA, USA).
Primer and Probe Design for Real-time PCR  
Primers and probes were designed by using the Beacon
Designer software, version 2.03, Premier (Biosoft
International, Palo Alto, CA, USA) (available from
http://www.premierbiosoft.com/molecular_beacons/), in
combination with manual manipulation. The primers and
probes used to amplify the K1, MAD20, RO33, and hybrid
(MAD20/RO33) allotypes of the block 2 region of msp1
and the internal control gene (erythrocyte-binding antigen
175, eba175) in P. falciparum are listed in Table 1, togeth-
er with information on fluorophores, melting temperatures,
final reactant concentrations, and the observed ranges of
amplicon sizes. Unlabeled primers and fluorophore-
labeled probes were obtained from Integrated DNA
Technologies (Coralville, IA, USA), LUX-labeled primers
from Invitrogen (Carlsbad, CA, USA); and the Cy5-
labeled probe for eba175  from Biosearch Technologies
(Novarto, CA, USA).  
Real-time PCR Amplification of Pathogen DNA
Real-time PCR was performed with the iCycler (Bio-
Rad) by using the amplification conditions described
below (Table 1) with a 2× multiplex-specific master mix
(Qiagen) and 3-µL aliquots of template DNA. Reaction
mixtures were supplemented with 2.5 U recombinant Taq
polymerase (Invitrogen) and subjected to an initial denatu-
ration at 95°C for 15 min, followed by 45 cycles of denat-
uration at 94° C for 30 s, annealing at 53°C for 90 s, and
extension at 72°C for 90 s. Fluorescence measurements
were obtained during the annealing step with TaqMan
probes (K1 and MAD20/RO33 hybrid allotypes, and the
eba175 internal control), and during the elongation step
with LUX primers (MAD20 and RO33 allotypes). Each
sample was tested in quadruplicate. Two samples were
used to define the allotypes present and their copy number
with the iCycler; the other 2 samples were removed from
the iCycler during the exponential (logarithmic) stage of
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genotypes present and genotype copy number. 
Template Specificity and Optimization 
of Multiplex PCR 
Template specificity was tested for each primer probe
set with the 4 control template DNAs (from Indochina I,
Haiti 135, 7G8 and hybrid MAD20/RO33 parasites).
Amplicons of the expected sizes were obtained with
matched template and primer probe sets; no amplicons
were obtained with unmatched template and primer probe
sets. Negative controls likewise yielded no amplicons.
DNAextracted from specimens without parasites was used
to control for primer-primer and primer-probe interactions,
and other potential causes of false-positive PCR results.
After establishing specificity, the reaction conditions were
optimized by defining the efficiencies of each primer
probe set using a series of 10-fold dilutions with each con-
trol template DNA. These efficiencies were then matched
to the efficiencies obtained with the multiplex PCR to
adjust the final primer and probe concentrations so the effi-
ciencies of the multiplex PCR matched those of the indi-
vidual PCRs. 
PCR Amplification and Allotype Quantitation 
Standard curves were generated by using 10-fold dilu-
tions of template DNA (3-µL aliquots) from each of the
control parasites to estimate the initial copy numbers of the
4 allotypes in each sample. The standard curves (regres-
sion lines) for each allotype, the resulting reaction efficien-
cies, threshold cycle (CT) values and estimates of initial
copy numbers were calculated by using the iCycler
Software (Bio-Rad).
Capillary Electrophoresis and Genotype Quantitation
To estimate amplicon size (base pairs) and copy num-
ber for each genotype, 2 replicates were removed from the
iCycler for each sample during the logarithmic amplifica-
tion stage, as determined by real-time relative fluorescence
unit (RFU) data, and stopped with 0.5 mol/L EDTA. For
each reaction, two 1-µLaliquots of the real-time PCR reac-
tion mixture were loaded onto a DNA 500 Lab Chip
(Agilent Technologies, Waldbronn, Germany) and run on
the Bioanalyzer 2100 (Agilent Technologies), according to
the manufacturer’s instructions. With capillary elec-
trophoresis using the DNA500 Lab Chip, a linear relation-
ship was shown between amplicon size and elution time
(r2>0.998, p<0.001 for amplicons from 25 bp to 400 bp;
data not shown). The copy numbers for each genotype
were calculated from the molarities provided by the
Agilent software. These calculations are based on the
observation that the concentration of each amplicon is pro-
portional to its peak area on the electropherogram. 
Results
Real-time PCR To Identify Pathogen Allotypes 
Real-time PCR with allotype-specific primers permits
the amplification of individual allotypes in specimens
from infected human subjects (first 3 columns of Table 2,
and Figure 1, panel A). Based on control specimens con-
taining only 1 allotype and on negative controls, this strat-
egy is specific. Based on filter paper blots for specimens
containing >100 parasites/µL, it is sensitive. However,
real-time PCR with allotype-specific primers does not dis-
tinguish among (identify) genotypes within allotypes
(Figure 1). This is because real-time PCR cannot identify
size polymorphisms, whether they result from natural
events such as the spontaneous addition and deletion of
tripeptide repeats in malaria parasites (14) or deliberately
malevolent manipulation of microorganisms in the labora-
tory as potential agents of bioterrorism. 
Optimization of Real-time PCR 
Estimates of efficiency (the degree to which replication
increases the number of amplicons by the expected 2-fold
increment [100% efficiency] in each cycle) indicate that
the efficiency of the real-time PCR assays performed in
these studies was excellent (90%–100%). In addition, effi-
ciencies of reactions in multiplex did not differ significant-
ly from individual reaction efficiencies or from other
reaction efficiencies in multiplex.
Reproducibility of Copy Number 
(Threshold Cycle, CT) Estimates 
Data for estimates of copy number were based on the
amplification of block 2 of msp1  from  P. falciparum
malaria parasites (Table 2). The reproducibility of CT esti-
mates was examined separately for exemplary 93- and
154-bp amplicons, and found to have means of 27.99 and
28.62 cycles, respectively, with standard deviations of 0.34
and 0.13 cycles (i.e., coefficients of variation [CVs] of
1.2% and 0.5% for these 2 amplicons, n = 10 for each). 
Capillary Electrophoresis To Identify 
Pathogen Genotypes 
In contrast to real-time PCR, which identifies only allo-
types, capillary electrophoresis identifies genotypes within
allotypes (based on size polymorphisms) in samples from
persons (Figure 1, panels B–D). Across participants (in
groups of samples), this method permits one to identify the
spectrum (range) of genotypes in the population (data for
samples from 10 persons infected with P. falciparum are
presented as an example in Figure 2 and Table 3). The
reproducibility of capillary electrophoresis is sufficient to
separate amplicons that differ by >5 bp. This conclusion
was based on a comparison of amplicons containing 148
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60.51 and 61.11 s, respectively (Figure 3).
Reproducibility of Genotype Copy Number Estimates 
Based on the electropherograms, the reproducibility of
peak area measurements and estimates of genotype copy
number was excellent. CVs varied from 0.13% to 0.45%
for amplicon concentrations between 10 nmol/L and 80
nmol/L (n = 12 replicates at each of 4 template concentra-
tions of a 95-bp amplicon from 10 nmol/L to 80 nmol/L,
data not shown).
Real-time Fluorescence in Relation to Peak Area 
The slopes of increasing fluorescence based on real
time PCR with the iCycler were indistinguishable from the
increasing peak areas on the electropherogram (Figure 4,
panels Aand B, slopes of 0.2252 and 0.2223, p > 0.5). The
similarity of these slopes (based on different parameters)
indicates that increases in RFUs are directly proportional
to increases in amplicon concentration (molarity). This
result permits one to extrapolate from allotype copy num-
ber to genotype copy number based on peak area.
Field Samples from Persons with Polyclonal Infections
Three of the 4 known P. falciparum allotypes have size
polymorphisms within block 2 of msp1. K1, MAD20, and
hybrid MAD20/RO33 allotype parasites have size poly-
morphisms because they contain tripeptide repeats within
block 2 of msp1; RO33 does not have size polymorphisms
because it does not have tripeptide repeats (15). These size
polymorphisms are evident for K1 in a sample from a sin-
gle person (Table 2) and for K1, MAD20, and hybrid
MAD20/RO33 parasites in samples from 10 persons
(Figure 2 and Table 3).
Discussion
Simultaneous Infection and Detection 
of Genetically Modified Organisms 
Studies by a number of investigators have shown that
simultaneous infection with multiple pathogens (geno-
types) of the same species occurs in patients with HIV,
hepatitis C, Epstein-Barr virus, dengue, tuberculosis, and
malaria (1–7) and have identified deletions and insertions
(genotypes) due to tandem repeats in cytomegalovirus
(15). Because pathogen genotypes based on insertions and
deletions are common, the strategy reported here is poten-
tially applicable to all microbial human pathogens. This
complexity of infection is likely to be important in the
pathogenesis and transmission of many emerging infec-
tious diseases. For example, epidemiologically and clini-
cally meaningful events such as severe disease and
antimicrobial drug resistance are likely to be driven by
competition among pathogen genotypes in vivo (by the
virulence and antimicrobial susceptibility/resistance deter-
minants of the predominant genotypes) and may also affect
transmission. 
In addition to block 2 of msp1 in P. falciparum, other
examples of natural sequence variation detectable by using
real-time PCR and capillary electrophoresis (variations >5
nucleotides/bp) include duplications and deletions in the 3′
noncoding regions (NCRs) of dengue (16) and yellow
fever (17) and insertions and deletions in the env gene of
HIV (18,19). For Mycobacterium tuberculosis, examples
include variation in the tandem repeats within IS6110 (20),
variable numbers of tandem repeats (VNTRs) (21), and
genomic deletions (22). For select agents, examples
include variation in VNTRs (multiple locus VNTR analy-
sis) in Bacillus anthracis (23,24), similar differences in
Yersinia pestis (25), and insertions, deletions, and variation
in the inverted terminal repeat region and the coding
region of the smallpox virus (26,27) (Table 4).
In addition, disease-producing agents may be modified
in the laboratory to increase their virulence or to introduce
antimicrobial drug resistance for bioterrorist events
(28–30). However, available methods are inadequate to
rapidly diagnose and quantitate simultaneous infection
with multiple pathogens (genotypes) of the same species or
identify insertions and deletions in critical regions of
pathogen genomes. The results reported here provide a
strategy to address these issues based on real-time PCR
and capillary electrophoresis. 
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Quantitate Pathogen Allotypes
As demonstrated here and elsewhere, allotype-specific
primers permit one to identify the pathogen allotypes in a
specimen (1–7). In addition, real-time PCR may be used to
quantitate the numbers of microorganisms in a specimen.
Because the relationship between the number of cycles
necessary to reach the CT and the log10 of copy number is
linear, real-time PCR can be used to estimate the initial
amount of template DNA (copy number) (8,9).
Capillary Electrophoresis To Identify 
and Quantitate Pathogen Genotypes 
In contrast to real-time PCR (in which all amplicons
[genotypes] are examined together in the same well once
each cycle), capillary electrophoresis detects the ampli-
cons from each genotype as they pass a fluorescence or
absorbance detector. This is accomplished by separating
dsDNAamplicons based on their size (base pairs) by using
a charged electrical field to drive the dsDNApolyanions to
the detector at the anode. Because this separation is driven
by the ratio of the electrical driving force to the mass of
each amplicon, the rate of movement to the anode is
inversely proportional to mass (size in base pairs). Thus,
smaller amplicons travel faster and have shorter retention
times on the electropherogram (Figure 1, panels B–D). 
Detection of Artificial-size Polymorphisms 
The results reported here demonstrate that capillary
electrophoresis is sufficiently sensitive to detect insertions
and deletions >5 bp in size. This finding means that capil-
lary electrophoresis is more than sufficiently sensitive to
detect biologically significant insertions and deletions in
genetically modified organisms (23–30). Thus, it provides
an open-ended strategy to test for genetically modified
organisms, by testing for size polymorphisms at critically
important sites in the pathogen genome, e.g., at sites relat-
ed to pathogenicity (virulence) or antimicrobial resistance. 
Advantages, Limitations, and Potential Pitfalls 
The advantages of real-time PCR followed by capillary
electrophoresis are that it can be performed without wait-
ing days or weeks for cultures to grow and that it detects
pathogens that do not grow in conventional culture media
or under standard conditions (31). In addition, as noted
above (14), sequence information is enormously helpful in
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Figure 1. Use of capillary elec-
trophoresis to identify multiple
genotypes within single allotypes
amplified by real-time polymerase
chain reaction. Panel A shows the
relative fluorescence values for 3
samples from infected patients by
using primers specific for the K1
allotype of merozoite surface pro-
tein 1 (msp1). Panels B, C, and D
show that those samples con-
tained 3, 4, and 1 different K1
genotype parasites, respectively,
identified by amplicons of 106,
124, and 142 bp (panel B), 105,
124, 142, and 160 bp (panel C),
and 160 bp (panel D), respectively.
The first and last peaks on each
electropherogram are the 15- and
600-bp standard markers used to
define the sizes of the unknown
amplicons.
Figure 2. Copy numbers for genotypes of the K1 allotype in 10 field
samples. Distribution of K1 genotypes within the 8 patients whose
samples yielded amplicons with K1-specific primers (Table 4).
These results indicate that most infected persons had  >2 allotypes.
In addition, persons with K1 allotype parasites had a high degree of
genotypic complexity, that is, capillary electrophoresis showed up
to 4 distinct K1 genotypes in the blood of individual patients at the
same time. selecting loci within the genome likely to have insertions
and deletions and interpreting the results obtained.
Although insertions, deletions, and single nucleotide poly-
morphisms (SNPs) produce detectable changes in melting
curves (32,33), melting curves are qualitative rather than
quantitative. In addition, melting curves alone cannot iden-
tify specific insertions, deletions, or quasispecies (SNPs)
without the addition of probes for the affected target region
of the genome or the use of PCR (34,35). Finally, because
the strategy reported here tests for size polymorphisms, it
does not require prior knowledge of the specific sequences
that may have been introduced into (or deleted from) the
pathogen genome to identify genetically modified organ-
isms. However, this strategy does have 3 limitations. 
First, sequences identical to (or cross-reactive with)
host sequences cannot be used as targets because blood
and tissue specimens are inevitably contaminated with
host DNA (this issue can be resolved by searching the
GenBank database). Second, the threshold of detection for
genetically modified organisms is the addition (or
removal) of sequences >5 bp (based on the sensitivity of
capillary electrophoresis), i.e., point mutations (SNPs =
quasispecies) (36–38) cannot be detected with this strate-
gy. As a result, this method is likely to be of greater value
for organisms with dsDNA genomes such as bacteria,
eukaryotic parasites, and dsDNA viruses (in which quasi-
species are less common because of more accurate replica-
tion) than for organisms with single negative-stranded
RNA genomes (in which quasispecies are more common
because their replication depends on the error-prone
reverse transcriptase—HIV, hepatitis C, hepatitis B)
(39,40). Third, capillary electrophoresis may need to be
performed separately for each allotype to avoid confusion
between amplicons of similar size from different allotypes
(Figures 1–3).
Conclusions 
The strategy reported here can be used for epidemiolog-
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pathogens (genotypes) of the same species in emerging
infectious diseases and for the rapid identification of select
agents that have been genetically modified to increase their
virulence or antimicrobial drug resistance. 
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